Suppr超能文献

狄氏剂诱导CF-1小鼠肝脏中同工酶组成的变化。

Dieldrin-induced changes in isoenzyme composition in the livers of CF-1 mice.

作者信息

van Ravenzwaay B, Toussaint H J, Schmitt R L

机构信息

German Cancer Research Centre, Institute of Biochemistry, Heidelberg.

出版信息

Int J Cancer. 1988 Feb 15;41(2):305-8. doi: 10.1002/ijc.2910410223.

Abstract

The isoenzyme composition of lactic dehydrogenase (LDH), pyruvate kinase (PK) and alanine-aminotransferase was determined in the livers of CF-1 mice exposed to 0, 5 or 10 ppm dieldrin in the diet, over a period of 14 months. This study was carried out to evaluate whether the liver tumor promoter dieldrin advances the biological age of CF-1 mouse liver. Oral dieldrin exposure induced a dose-dependent shift towards the fetal types of lactic dehydrogenase and pyruvate kinase, within 1.5 months of initiation of treatment. After the initial shift, no additional dieldrin-dependent changes were found in CF-1 mouse liver throughout the experimental observation period. Thus, the initial shifts in isoenzyme composition of LDH and PK appear to reflect the adaptation of the liver to increased functional demands imposed by dieldrin treatment. The expression of the cytoplasmic A-alanine-aminotransferase isoenzyme decreased with age in untreated control mice. Dieldrin treatment enhanced this process in a dose-dependent manner. These data suggest that dieldrin treatment can accelerate age-dependent changes in gene expression.

摘要

在14个月的时间里,测定了饮食中接触0、5或10 ppm狄氏剂的CF-1小鼠肝脏中乳酸脱氢酶(LDH)、丙酮酸激酶(PK)和丙氨酸转氨酶的同工酶组成。进行这项研究是为了评估肝脏肿瘤促进剂狄氏剂是否会使CF-1小鼠肝脏的生物学年龄提前。口服狄氏剂暴露在治疗开始后的1.5个月内,诱导了乳酸脱氢酶和丙酮酸激酶向胎儿型的剂量依赖性转变。在最初的转变之后,在整个实验观察期内,CF-1小鼠肝脏中未发现额外的狄氏剂依赖性变化。因此,LDH和PK同工酶组成的最初转变似乎反映了肝脏对狄氏剂治疗增加的功能需求的适应。在未处理的对照小鼠中,细胞质A-丙氨酸转氨酶同工酶的表达随年龄下降。狄氏剂治疗以剂量依赖性方式增强了这一过程。这些数据表明,狄氏剂治疗可以加速基因表达中与年龄相关的变化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验